# A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine

> **NCT03836664** · PHASE2 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 25 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Timolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03836664
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-27
- **Primary completion:** 2018-04-14
- **Final completion:** 2018-04-14
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03836664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03836664, "A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03836664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*